Atlas Trials

Efficacy and Tolerability of Zolmitriptan Nasal Spray

Clinical trial NCT00617747 · COMPLETED

Trial details

NCT number
NCT00617747
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Migraine
Start date
2002-09-01
Enrollment
2114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.